BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712 AND Treatment
41 results:

  • 1. Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review.
    Li C; Li K; Zhong S; Tang M; Shi X; Bao Y
    Crit Rev Oncol Hematol; 2024 Feb; 194():104227. PubMed ID: 38220124
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Deuterium Magnetic Resonance Spectroscopy Quantifies tumor Fraction in a Mouse Model of a Mixed Radiation Necrosis / GL261-Glioblastoma Lesion.
    Song KH; Ge X; Engelbach J; Rich KM; Ackerman JJH; Garbow JR
    Mol Imaging Biol; 2024 Feb; 26(1):173-178. PubMed ID: 37516675
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
    Moore-Palhares D; Chen H; Keith J; Wang M; Myrehaug S; Tseng CL; Detsky J; Perry J; Lim-Fat MJ; Heyn C; Maralani P; Lipsman N; Das S; Sahgal A; Soliman H
    J Neurooncol; 2023 Jul; 163(3):541-551. PubMed ID: 37256526
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 Patients.
    Lehrer EJ; Gurewitz J; Bernstein K; Kondziolka D; Fakhoury KR; Rusthoven CG; Niranjan A; Wei Z; Lunsford LD; Malouff TD; Ruiz-Garcia H; Peterson JL; Bonney P; Hwang L; Yu C; Zada G; Deibert CP; Prasad RN; Raval RR; Palmer JD; Patel S; Picozzi P; Franzini A; Attuati L; Mathieu D; Trudel C; Lee CC; Yang HC; Jones BM; Green S; Ahluwalia MS; Sheehan JP; Trifiletti DM
    Neurosurgery; 2022 Dec; 91(6):872-882. PubMed ID: 36255215
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: A systematic review and meta-analysis.
    Bhandari A; Marwah R; Smith J; Nguyen D; Bhatti A; Lim CP; Lasocki A
    J Med Imaging Radiat Oncol; 2022 Sep; 66(6):781-797. PubMed ID: 35599360
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Distinguishing tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
    Feng A; Yuan P; Huang T; Li L; Lyu J
    Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
    Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
    Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Renal Primitive Neuroectodermal tumor With Inferior Vena Cava Thrombus: Case Series and Literature Review of a Rare but Challenging Entity.
    Xu C; Sun Z; Xiao R; He W; Ma L
    Clin Genitourin Cancer; 2021 Oct; 19(5):e273-e279. PubMed ID: 33941490
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review.
    Kulinich DP; Sheppard JP; Nguyen T; Kondajji AM; Unterberger A; Duong C; Enomoto A; Patel K; Yang I
    Acta Neurochir (Wien); 2021 Jul; 163(7):1921-1934. PubMed ID: 33796887
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas.
    Hadi I; Reitz D; Bodensohn R; Roengvoraphoj O; Lietke S; Niyazi M; Tonn JC; Belka C; Thon N; Nachbichler SB
    Radiat Oncol; 2021 Feb; 16(1):40. PubMed ID: 33622365
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
    Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
    Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Advanced multimodal imaging in differentiating glioma recurrence from post-radiotherapy changes.
    Li C; Gan Y; Chen H; Chen Y; Deng Y; Zhan W; Tan Q; Xie C; Sharma HS; Zhang Z
    Int Rev Neurobiol; 2020; 151():281-297. PubMed ID: 32448612
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. 2-[
    Verhoeven J; Baguet T; Piron S; Pauwelyn G; Bouckaert C; Descamps B; Raedt R; Vanhove C; De Vos F; Goethals I
    Nucl Med Biol; 2020; 82-83():9-16. PubMed ID: 31841816
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A multi-institutional analysis of clinical outcomes and patterns of care of 1p/19q codeleted oligodendrogliomas treated with adjuvant or salvage radiation therapy.
    Lin AJ; Kane LT; Molitoris JK; Smith DR; Dahiya S; Badiyan SN; Wang TJC; Kruser TJ; Huang J
    J Neurooncol; 2020 Jan; 146(1):121-130. PubMed ID: 31741234
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Intraoperative radiotherapy for glioblastoma: an international pooled analysis.
    Sarria GR; Sperk E; Han X; Sarria GJ; Wenz F; Brehmer S; Fu B; Min S; Zhang H; Qin S; Qiu X; Hänggi D; Abo-Madyan Y; Martinez D; Cabrera C; Giordano FA
    Radiother Oncol; 2020 Jan; 142():162-167. PubMed ID: 31629553
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Oligodendroglioma confers higher risk of radiation necrosis.
    Ahmad H; Martin D; Patel SH; Donahue J; Lopes B; Purow B; Schiff D; Fadul CE
    J Neurooncol; 2019 Nov; 145(2):309-319. PubMed ID: 31549281
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
    Donovan EK; Parpia S; Greenspoon JN
    Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma.
    Fleischmann DF; Jenn J; Corradini S; Ruf V; Herms J; Forbrig R; Unterrainer M; Thon N; Kreth FW; Belka C; Niyazi M
    Radiother Oncol; 2019 Sep; 138():99-105. PubMed ID: 31252301
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
    Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
    J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy for Recurrent Malignant Gliomas: A Systematic Review and Meta-analysis.
    Hu YJ; Chen D; Zhang LF; Chen J
    World Neurosurg; 2019 Jul; 127():176-185. PubMed ID: 30959254
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.